Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Main Content

Industry Professionals: MDS Emerging On Demand Therapies in Parkinson’s Disease Virtual Course

CME Credits:0Date:Nov 19, 2021 - Dec 10, 2021

Foundational / Beginner

Program Description

The MDS Emerging On Demand Therapies in Parkinson’s Disease Virtual Course for Industry Professionals will address the critical role for pharmaceuticals and devices in this area.  Parkinson’s disease is now the fastest growing neurological disorder on the planet and with this growth there will be an expanding need for therapies.  We will in this course explore the “why” of on demand therapies in Parkinson’s disease.  We will discuss the many approaches from pills, patches, pumps and surgical approaches.  We will summarize the current state of the field and also discuss the unmet critical needs in Parkinson’s disease.

Topics

  • Parkinson Disease/Hypokinetic Movement Disorders
  • Therapies-Surgical

Faculty

Course Director
Michael Okun, MD - University of Florida Fixel Institute for Neurological Diseases, Gainesville, FL, USA

Faculty
Susan Fox, MRCP (UK), PhD - Univ. of Toronto, Toronto Western Hospital, Toronto, ON, Canada
Irene Malaty, MD, FAAN - University of Florida, Gainesville, FL, USA

Course Purpose

The primary purpose of this program is to address the critical role for pharmaceuticals and devices in emerging on demand therapies in Parkinson's disease.

Lectures will be available for on-demand viewing beginning on November 19, 2021 until December 31, 2021.

Registration Fees
Members: $75 USD
Non-Members: $75 USD

To view the course schedule please click 'PROCEED TO COURSE'.

Learning Objectives

Upon completion of this activity learners will be able to:
1. To review the current pharmacological on demand approaches for the treatment of Parkinson’s disease
2. To review the emerging delivery systems for Parkinson’s disease on demand therapy drugs
3. To review emerging surgical approaches to on demand issues in Parkinson’s disease

Intended Audience

This activity is intended for industry professionals who work for pharmaceutical and medical device companies.

Hardware and Software Requirements

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher)
5. Adobe Reader to print certificate

Contact Us

MDS Development

MDS Secretariat Liaison

Ken Buesing

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice